[1]玉艳红,原彤彤,黄力毅,等.外周血单核细胞hFgl2蛋白表达与不同临床类型肝病的关系[J].南方医科大学学报,2013,(03):436.
点击复制

外周血单核细胞hFgl2蛋白表达与不同临床类型肝病的关系()
分享到:

《南方医科大学学报》[ISSN:1673-4254/CN:44-1627/R]

卷:
期数:
2013年03期
页码:
436
栏目:
出版日期:
2013-03-15

文章信息/Info

Title:
hFgl2 protein expression in peripheral blood mononuclear cells in different clinical types of liver disease
作者:
玉艳红原彤彤黄力毅吴继周李国坚吴健林
关键词:
hFgl2慢性乙型肝炎肝癌外周血单核细胞
Keywords:
hFgl2 chronic hepatitis B liver cancer peripheral blood mononuclear cells
摘要:
目的探讨人纤维介素蛋白-2凝血酶原酶(hFgl2)在慢性乙型肝炎及肝癌患者外周血单核细胞中的表达及其与慢性乙型
肝炎病情严重程度之间的关系。方法测定慢性乙型肝炎轻、中、重度,慢性重型乙型肝炎,肝癌患者共78例外周血单核细胞
hFgl2 蛋白的表达进行比较,并将其与配对患者谷丙转氨酶(ALT)、谷草转氨酶(AST)及总胆红素(TBiL)行相关分析。结果
hFgl2蛋白可以表达于外周血单核细胞,在慢重肝组和肝癌组表达高于对照组和慢乙肝组,而慢重肝组表达高于肝癌组。慢乙
肝重度组hFgl2蛋白的表达与其ALT、AST及TBiL成正相关。结论hFgl2蛋白可以表达于外周血单核细胞并呈现随着肝病严
重程度增加而表达升高的趋势。
Abstract:
Objective To detect hFgl2 expression in peripheral blood mononuclear cells in patients with chronic hepatitis B and
liver cancer and explore its association with the severity of chronic hepatitis B. Methods The protein expression of hFgl2 in
peripheral blood mononuclear cells was detected in 78 patients with chronic hepatitis B (including mild, moderate, or severe
cases), chronic severe hepatitis, or liver cancer, with 20 healthy volunteers as controls. The data were analyzed in comparison
with the patients’ alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total bilirubin (TBiL and) levels.
Results hFgl2 protein expression was significantly higher in patients with chronic severe hepatitis and liver cancer than in the
healthy volunteers and patients with chronic hepatitis B. The patients with chronic severe hepatitis had significantly higher
hFgl2 protein expression than patients with liver cancer. In severe cases of chronic hepatitis B, hFgl2 protein expression was
positively correlated with ALT, AST and TBiL, but these correlations were not found in mild or moderate cases. Conclusions
Peripheral blood mononuclear cells express hFgl2 protein, whose expression level increases with the severity of chronic
hepatitis B.

相似文献/References:

[1]梁建新,屈杏芬,曾文铤,等. 氧化苦参碱在治疗慢性乙型肝炎中抗肝纤维化的作用机制[J].南方医科大学学报,2010,(08):1871.
 LIANG Jian-xin,QU Xing-fen,ZENG Wen-ting,et al.Mechanism of oxymatrine in preventing hepatic fibrosis formation in patients with chronic hepatitis B[J].Journal of Southern Medical University,2010,(03):1871.
[2]阎丽,王战会,杨洁,等.恩替卡韦联合阿德福韦酯对既往核苷类似物治疗失败的慢性乙肝患者疗效分析[J].南方医科大学学报,2011,(06):1009.
[3]陈建蓉,王霁,秦天强,等.复方甘草酸苷治疗慢性乙型肝炎的效果及安全性的meta分析[J].南方医科大学学报,2014,(08):1224.
[4]苏荣,罗娜,杨延斌,等.HBeAg阴性慢性乙型肝炎患者乙肝病毒基因变异和分型研究[J].南方医科大学学报,2012,(12):1804.
[5]游志毅,周福元,王雄虎,等.APOBEC3G基因多态性与慢性乙型肝炎易感性的关系[J].南方医科大学学报,2013,(05):769.
[6]刘志威,陈友鹏.阿德福韦酯导致胸痛、低磷血症2例报告[J].南方医科大学学报,2013,(09):1407.
[7]张鑫,孙学华,周振华,等.SRC同源区2结构域蛋白基因多态性与慢性乙型肝炎易感性的关系[J].南方医科大学学报,2014,(04):468.
[8]曾磊,丁爱娇,江凌晓,等.广州市慢性乙型肝炎患者表面抗原水平分析[J].南方医科大学学报,2014,(07):974.
[9]张卡,舒欣,骆海飞,等.慢性乙型肝炎患者PBMCs中ROG、GATA3和T-bet mRNA水平及其意义[J].南方医科大学学报,2016,(02):186.
[10]陈文莉,罗鸣,陈小苹,等.慢性乙型肝炎同病异证发病的分子机制:蛋白质组学分析[J].南方医科大学学报,2016,(03):410.

更新日期/Last Update: 1900-01-01